RCM
GILD icon

Rotella Capital Management’s Gilead Sciences GILD Stock Holding History

Rotella Capital Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-4,500
Closed -$455K – 116
2015
Q4 		$455K Sell
4,500
-8,800
-66% -$916K 0.41% 54
2015
Q3 		$1.31M Buy
13,300
+10,929
+461% +$1.21M 0.42% 64
2015
Q2 		$278K Sell
2,371
-589
-20% -$64.4K 0.23% 106
2015
Q1 		$291K Buy
2,960
+660
+29% +$67K 0.24% 100
2014
Q4 		$217K Buy
+2,300
New +$238K 0.19% 127

Other funds holding GILD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Rotella Capital Management's GILD Position: Q1 2016 in Review

Rotella Capital Management sold out of Gilead Sciences (GILD) in Q1 2016, closing a stake of 4,500 shares — an estimated $455K sold.

Rotella Capital Management first reported a position in GILD in Q4 2014 and held it in 5 quarters. The position peaked at $1.31M in Q3 2015. 1,630 funds tracked by Wall St. Rank hold GILD as of Q1 2016.

  • Rotella Capital Management reported no remaining Gilead Sciences position as of Q1 2016 after selling out during the quarter.
  • Rotella Capital Management sold 4,500 Gilead Sciences shares in Q1 2016, an estimated $455K.
  • Rotella Capital Management first reported a position in Gilead Sciences in Q4 2014 and held it in 5 quarters.
  • Rotella Capital Management's Gilead Sciences position peaked at $1.31M in Q3 2015.
  • 1,630 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2016.

Based on Rotella Capital Management's 13F filing for Q1 2016, filed 13 May 2016.